AzTrials
AzTrials

Pregnancy RelatedEmbarAppNCT05424237

Efficacy and Feasibility of an eHealth Intervention for Pregnant Women on Diet, Physical Activity and Knowledge Related to Pregnancy

A study testing App intervention in people with Pregnancy Related, run by University of Oviedo at 1 site in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

A pragmatic clinical trial are developed with the aim to assess the effectiveness and feasibility of using an app as complement of the usual care that receive pregnancy women in a sanitary area in the Principado de Asturias (Spain). Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Pregnancy Related
What is being tested?
App intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
153 participants
Where
1 siteSpain
Study dates
1 May 2022to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged over 18
  • pregnant with only 1 fetus
  • low risk pregnancy
  • smartphone Access
  • signed the informed consent

Who cannot join

  • non-fluent Spanish speaker
  • do not fill the baseline or post-intervention questionnaires

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Oviedo

    Oviedo, Principality of Asturias, 33006

Other trials in Spain

About this study

A pragmatic clinical trial are developed with the aim to assess the effectiveness and feasibility of using an app as complement of the usual care that receive pregnancy women in a sanitary area in the Principado de Asturias (Spain).

Participants are pregnancy women attended in the sanitary area number 3 of the Pincipado de Asturias. As inclusion criteria we will consider: i) aged over 18; ii) pregnant with only 1 fetus; iii) low risk pregnancy; iv) smartphone Access; v) signed the informed consent. As exclusion criteria: i) non-fluent Spanish speaker; ii) do not fill the questionnaires.

Read more

A randon sample of 153 women will be recruited consequtively, at the first triemester, from the midwife consulting room. Those women to agreed to participate, and sign the infomred consent, will be anonymizated using a alphanumerical code and asigned (according to a previous randomization distribution by code) to a control or an intervention group.

All women are going to receive the baseline and post intervention questionnaires by email. All women are going to receive the usual care. Adittionally, those in the intervention group, will be prompted to use iNATAL app.

The following questionnaires and measures will be used: uMARS Questionnaire to assess and percentage of app usage tot assess the feasibility; to assess the effectiveness: Motiva.Diaf to assess dietary and physical activity recommendations; ad hoc questionnaire to assess knwoldedge pregnancy related; mother complications during of after the pregnancy period and newborn complications.

The intervention takes all pregnancy period.

Being tested
App intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • App interventionBehavioural

    usual care plus app ussage with the aim of promote healthy behaviors (diet, physical activity and weight)

Study groups in NCT05424237
Study groupRoleWhat they receive
Control groupNo intervention1. Sign consent form and baseline assessments 2. Usual care 3. Post intervention assessments
Interention groupExperimental1. Sign consent form and baseline assessments 2. Usual care + app iNATAL 3. Post intervention assessments
Receives: Behavioral: App intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Following dietary recommendations (mean)

    For both groups. Compliance with dietary recommendations. We are going to use the Motiva.Diaf questionnaire. It includes 7 questions to assess healthy diatery adherence. Response in dichotomous option 0 (not follow the recommendation) or 1 (follow the recommendation). Total score range from 0 (null dietary compliance) to 7 (best dietary compliance).

    Measured: Change from Baseline dietary recommendations at 8 or 9 months (depending the pregnancy)

  2. Following physical activity recommendations (mean)

    For both groups. Compliance with dietary recommendations. We are going to use the Motiva.Diaf questionnaire. It includes 5 questions to assess healthy diatery adherence. Response in dichotomous option 0 (not follow the recommendation) or 1 (follow the recommendation). Total score range from 0 (null dietary compliance) to 5 (best dietary compliance).

    Measured: Change from Baseline dietary recommendations at 8 or 9 months (depending the pregnancy)

  3. Change in pregnancy knwoledge (mean)

    For both groups. Ad hoc questionnaire that includes 10 questions related with pregnancy care. Response in dichotomous option 0 (wrong answer) or 1 (correct answer). Total score range from 0 (null knowledge) to 7 (best knowledge).

    Measured: Change from Baseline dietary recommendations at 8 or 9 months (depending the pregnancy)

  4. App ussage

    Only for intervention group. Use the app during pregnancy period time. Dichotomous answer (yes or not).

    Measured: At the end of the intervention (8-9 after baseline)

  5. Newborn complications (mean)

    Number of complication suffer by the newborn in the first week after the birth.

    Measured: From birth to one week after.

  6. Women weigh gain (mean)

    Weigh improvement in kilograms during the pregnancy period time

    Measured: From baseline to the end of the intervention (8-9 months after baseline)

  7. App quality (mean)

    Only for intervention group. We are going to use the Spanish version of uMARS to assess the objective and subjetive quality of the app. Both dimensions has a total score range from 1 (lowest quality) to 5 (higher quality).

    Measured: At the end of the intervention (8-9 after baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2022
  2. Study start1 May 2022
  3. Primary completion26 Dec 2024
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
153 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05424237
Sponsor's protocol ID
2021.490
Acronym
EmbarApp
Status last verified
Dec 2024
First submitted
14 Jun 2022
Last updated
27 Dec 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing App intervention in people with Pregnancy Related, run by University of Oviedo at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Following dietary recommendations (mean) (time frame: Change from Baseline dietary recommendations at 8 or 9 months (depending the pregnancy)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in